<DOC>
	<DOCNO>NCT01761058</DOCNO>
	<brief_summary>The overall goal proposal well understand basis airway remodel severe asthma remodel change overtime . The investigator propose study well characterize cohort individual severe asthma use multidisciplinary state-of-the-art-approach .</brief_summary>
	<brief_title>Severe Asthma Research Program - University Virginia</brief_title>
	<detailed_description>Through innovative metabolomics redox biochemistry , methodology strength unique collaborative effort , investigator identify clinically relevant phenotype asthma . The phenotype define biomarkers specific underlie biochemical mechanistic abnormality , include eosinophil-mediated oxidation , depletion antioxidant protective airway S-nitrosothiols , airway acidification . Here , investigator propose study new component informative longitudinal assessment severe asthma phenotype : gender effect . The investigator reason identification metabolic mechanism ( ) underlie onset severe asthma young woman adolescence , resolution severe asthma boy , reveal fundamental pathophysiology severe asthma . Importantly , aim develop clinical testing procedure accurately assign metabolic asthma phenotype ; follow patient phenotype uncover clinical longitudinal outcome . At conclusion project , anticipate 1 ) develop clinically relevant test identify severe asthma phenotype ; 2 ) determine longitudinal outcome phenotype ; 3 ) identify mechanisms underlying preponderance woman severe asthma population . This application focus development clinically relevant metabolic test identify subphenotypes adult child severe asthma lead new target innovative treatment .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Physician diagnosis asthma • Age 6 year 17 year old Evidence historical reversibility , include either ; 1 . FEV1 bronchodilator reversibility great equal 12 % , 2 . Airway hyperresponsivesness reflect methacholine PC20 le equal 16 mg/ml . Exclusion criterion include follow : 1 . Pregnancy characterization phase* , 2 . Current smoking , 3 . Smoking history &gt; 10 pack year ≥30 year age , smoke history &gt; 5 pack year &lt; 30 year age ( Note : subject smoke history , smoke within past year ) , 4 . Other chronic pulmonary disorder associate asthmalike symptom , include ( limited ) cystic fibrosis , chronic obstructive pulmonary disease , chronic bronchitis , vocal cord dysfunction ( sole cause respiratory symptom PI 's discretion ) , severe scoliosis chest wall deformity affect lung function , congenital disorder lung airway , 5 . History premature birth 35 week gestation , 6 . Unwillingness receive intramuscular triamcinolone acetonide injection . 7 . Evidence participant family may unreliable poorly adherent asthma treatment study procedure , 8 . Planning relocate clinical center area study completion , 9 . Any criteria place subject unnecessary risk accord judgment Principal Investigator and/or attend physician ( ) record , 10 . Currently participate investigational drug trial .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Bronchial Diseases</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
	<keyword>Lung Diseases , Obstructive</keyword>
	<keyword>Lung Diseases</keyword>
	<keyword>Respiratory Hypersensitivity</keyword>
	<keyword>Hypersensitivity , Immediate</keyword>
	<keyword>Hypersensitivity</keyword>
	<keyword>Immune System Disease</keyword>
</DOC>